2021: Looking back on a year of ME/CFS research
It’s the end of December, so time to review the most interesting scientific research findings
Continue reading2021: Looking back on a year of ME/CFS research
A historic change for the ME/CFS community
Today, on 29 October 2021, the National Institute for Health and Care Excellence (NICE) has
A summary of the Massachusetts ME/CFS conference
On 23 October 2021, the Massachusetts ME/CFS & FM Association organized an online conference titled
Continue readingA summary of the Massachusetts ME/CFS conference
InTime: the results of Cortene’s CT38 trial
Cortene Inc., an American pharmaceutical company, recently published findings of a preliminary treatment trial in
Comments on the CDC evidence review on ME/CFS
In a previous blog post, we summarized the draft report of a systematic review on
Continue readingComments on the CDC evidence review on ME/CFS
Summary of the CDC evidence review
The Centers for Disease Control and Prevention (CDC) have commissioned a systematic review on the
Problems with the MetaBLIND study
The MetaBLIND study is likely the largest study on the effect of blinding in randomized
What long-term follow-up data tell us about the evidence on GET and CBT
After years of waiting, the long-term follow-up results of the GETSET study have finally been
Continue readingWhat long-term follow-up data tell us about the evidence on GET and CBT
The dark psychosomatic history of schizophrenia
This blog post explores the dark psychosomatic history of schizophrenia. In the first decades after
Continue readingThe dark psychosomatic history of schizophrenia
The dark psychosomatic history of autism
In this blog post, we look at the dark psychosomatic history of autism. Shortly after